Penumbra, Inc.
Market Cap
13B
Short interest (Jul 15)
5.4%
Net Short (Jul 27 ): -0.1%
Borrow Fee
0.81%
↓ 31.3%
Available Shares
2M
↓ 23.7%
Price Chart
Company Overview
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.